Developing Countries Push to Limit Patent Protections for Covid-19 Vaccines

A team of developing nations around the world, backed by United Nations businesses and activist groups, is pushing to limit patent protections for Covid-19 vaccines currently being examined by some of the world’s most important pharmaceutical companies so that cheap copies can be created for poorer nations.

South Africa, Ghana, Senegal, Pakistan and some others argue they won’t be in a position to find the money for to defend their people devoid of reduce-charge, generic options to the vaccines now currently being examined by companies such as Pfizer Inc., AstraZeneca PLC and Moderna Inc.

…